Clinical trials for gastrointestinal stromal tumor (GIST)
Soft tissue sarcomas located in the digestive system are referred to as Gastrointestinal stromal tumors (GIST). Symptoms of GIST include anemia, abdominal pain, nausea, and vomiting. There are only between 4,000 to 6,000 new cases each year,...
Soft tissue sarcomas located in the digestive system are referred to as Gastrointestinal stromal tumors (GIST). Symptoms of GIST include anemia, abdominal pain, nausea, and vomiting. There are only between 4,000 to 6,000 new cases each year, making it a rare cancer type.
The most common treatment for these patients is surgery to remove the tumor, unless too large or in a location compromised by too many organs. For these patients, clinical trials provide alternative treatment options. Thanks to clinical trials, there have been significant advances in the research and treatment of GIST in the past decade. Targeted treatments now used as standard of care, were developed in clinical trials. Today, clinical trials continue to offer early access to new and alternative treatments. For those seeking treatment, Massive Bio’s SYNERGY AI: Clinical Trial Matching System (CTMS) searches through all the available trials near you and determines which is best for your case based on 170 clinical algorithms.
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.